₹0.5
▲ +0.02 +4.17%
18 Jul 2026
BSE Listed
Suncare Traders Limited (539526)
Volume: 11,07,024Avg Vol 1W: 4,01,655Avg Vol 1M: 4,84,59552W Range:₹0.4₹0.98
Key Ratios
Checked just nowMarket Cap₹13 Cr
Current Price₹0.5
Previous Close₹0.48
High / Low (52w)₹0.98 / ₹0.4
Volume11,07,024
Avg Vol (1W)4,01,655
Avg Vol (1M)4,84,595
Stock P/E—
Book Value₹2.2
Dividend Yield0%
ROE-68.59%
ROA12.79%
Revenue (TTM)—
Revenue Growth—
Profit Margin57.64%
Total Debt—
Shares Outstanding26 Cr
Face Value—
EPS (TTM)₹0
P/B0.23
Debt / Equity0.13
50 DMA₹0.48
200 DMA₹0.64
Day change+4.17%
Price Chart
₹0.5▼ 47.92% · 1Y
2025-07-172026-07-17
20-day avg volume: 4.8L shares
Pros
- Company is almost debt-free.
- Revenue grew 133% YoY.
- Net profit is growing year over year.
- Stock trades below its book value.
Quarterly Results
| Metric | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹2 Cr | ₹1 Cr | ₹3 Cr | ₹3 Cr | ₹5 Cr | ₹3 Cr | ₹1 Cr | ₹2 Cr |
| EBITDA | ₹0 Cr | ₹0 Cr | ₹1 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹1 Cr |
| Net Profit | ₹0 Cr | ₹0 Cr | ₹1 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| EPS | — | — | — | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 |
|---|---|---|---|---|---|---|---|
| Revenue | ₹9 Cr | ₹8 Cr | ₹6 Cr | ₹6 Cr | ₹6 Cr | ₹5 Cr | ₹13 Cr |
| EBITDA | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹1 Cr | ₹0 Cr | ₹1 Cr |
| Net Profit | ₹-1 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹-1 Cr | ₹0 Cr | ₹1 Cr |
| EPS | -3.79 | 0.29 | 0.21 | 0.18 | -0.07 | 0 | 0.04 |
Balance Sheet
| Metric | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 |
|---|---|---|---|---|---|---|---|
| Total Assets | ₹40 Cr | ₹40 Cr | ₹44 Cr | ₹44 Cr | ₹43 Cr | ₹43 Cr | ₹47 Cr |
| Total Liabilities | ₹2 Cr | ₹2 Cr | ₹5 Cr | ₹4 Cr | ₹5 Cr | ₹5 Cr | ₹8 Cr |
| Equity | ₹38 Cr | ₹38 Cr | ₹39 Cr | ₹39 Cr | ₹38 Cr | ₹38 Cr | ₹39 Cr |
| Total Debt | — | — | — | — | — | — | — |
Cash Flow
| Metric | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 |
|---|---|---|---|---|---|---|---|
| Operating | ₹0 Cr | ₹1 Cr | ₹0 Cr | ₹0 Cr | ₹-1 Cr | ₹-1 Cr | ₹2 Cr |
| Investing | ₹-24 Cr | ₹0 Cr | ₹-3 Cr | ₹0 Cr | ₹1 Cr | ₹1 Cr | ₹-4 Cr |
| Financing | ₹24 Cr | ₹0 Cr | ₹3 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹2 Cr |
| Free Cash Flow | ₹0 Cr | ₹1 Cr | ₹0 Cr | ₹0 Cr | ₹-1 Cr | ₹-1 Cr | ₹2 Cr |
Shareholding
Promoter 4.29% Institutions 0% Public 95.71%
Efficiency & Working Capital
ROCE0.5%
Interest Coverage1.4
Dividend Payout—
Debtor Days17 d
Inventory Days39 d
Payable Days26 d
Cash Conversion Cycle30 d
Working Capital Days55 d
Shareholding Details
As of 2026-03-31
Promoter4.3%
FII0%
DII0%
Institutions0%
Public95.7%
Promoter Pledge0%
No. of Shareholders1,18,664
Shareholding Pattern
Quarterly — figures in %. Latest 12 quarters.
| Period | Sept 2023 | Nov 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 4.4% | 4.4% | 4.3% | 4.3% | 4.3% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 95.6% | 95.6% | 95.7% | 95.7% | 95.7% |
| Promoter Pledge | — | — | — | — | — | — | — | 0% | 0% | 0% | 0% | 0% |
| No. of Shareholders | 74,501 | 81,677 | 1,00,764 | 1,21,419 | 1,21,769 | 1,22,568 | 1,24,385 | 1,23,725 | 1,22,958 | 1,22,022 | 1,20,317 | 1,18,664 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202503 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Nilmesh Infrabuild Llp | Public Shareholding | 11.8% | 3.00 Cr |
| Shree Ganesh Bio Tech India Limited | Public Shareholding | 5.3% | 1.35 Cr |
| Saianand Commercial Limited | Public Shareholding | 4.9% | 1.25 Cr |
| Biogen Pharmachem Industries Limited | Shareholding of Promoter and Promoter Group | 4.3% | 1.09 Cr |
| Amerise Biosciences Limited | Public Shareholding | 3.9% | 1.00 Cr |
Promoter Pledges
| Holder | Pledged Shares | % of Holding | As of |
|---|---|---|---|
| Biogen Pharmachem Industries Limited | 0 | 0% | 2026-03-31 |
| Amerise Biosciences Limited | 0 | 0% | 2026-03-31 |
| Saianand Commercial Limited | 0 | 0% | 2026-03-31 |
| Shree Ganesh Bio Tech India Limited | 0 | 0% | 2026-03-31 |
| Nilmesh Infrabuild Llp | 0 | 0% | 2026-03-31 |
| Biogen Pharmachem Industries Limited | 0 | 0% | 2025-12-31 |
| Saianand Commercial Limited | 0 | 0% | 2025-12-31 |
| Amerise Biosciences Limited | 0 | 0% | 2025-12-31 |
| Siddhi Power Limited | 0 | 0% | 2025-12-31 |
| Shree Ganesh Bio Tech India Limited | 0 | 0% | 2025-12-31 |
| Shah Enterjrise | 0 | 0% | 2025-12-31 |
| Biogen Pharmachem Industries Limited | 0 | 0% | 2025-09-30 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| Dineshkumar Tribhovanbhai Rathod | Independent Non Exe. Director | 2025 |
| Kartik Raval | Independent Non Exe. Director | 2025 |
| Narendrakumar Vaniya | Independent Non Exe. Director | 2025 |
| Harshadkumar Rathod | Executive Director / Whole Time Director / CFO | 2025 |
| Chhaya Parmar | Independent Non Exe. Director | 2025 |
| Pareshbhai Sengal | Non-Exec & Non-Independent Dir | 2025 |
| Manju Sharma | Company Sec. & Compli. Officer | 2025 |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2025 | ₹2 | 51 | 51 | 51 |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2025 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 0 | 0 | 0 | 0 |
Substantial Acquisitions (SAST)
5 disclosure(s)
Off Market11/07/2025 · 3,00,00,000
Off Market11/07/2025 · 3,00,00,000
Pref. Allotment20/10/2023 · 2,66,70,000
Pref. Allotment20/10/2023 · 3,00,00,000
Pref. Allotment20/10/2023 · 3,00,00,000
Company Information
Incorporated1997
AuditorDoshi Maru & Associates/Goenka Mehta & Associates
Investor Email[email protected]
📍 7 Shree Shakti Estate Behind, Milan Complex Sarkhej, Ahmedabad, Gujarat, 382210
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search